Products

All the Multilayer Flow Modulator (MFM®) devices share the unique capabilities that benefit both patients and medical staff:

  • Restoration of healthy laminar blood flow
  • Preservation of branch artery patency
  • Formation of organized stable thrombus
  • Rapid endothelialization along the vessel wall
  • Efficient minimally invasive implantation procedure

Aortic MFM®

Intended use

The Aortic MFM® is currently CE-mark approved for the endovascular treatment of patients with unruptured complex aortic aneurysms (aortic aneurysm involving at least one branch artery) with morphology suitable for endovascular repair.

Features

  • Physiological remodeling and healing of the aneurysmal artery while maintaining branch vessel patency and improving perfusion
  • Endothelialization and integration, as the uncovered device allows endothelial tissue to be generated on the braided structure
  • The flared ends of the Aortic MFM® promote compliance with the aortic wall and ensure optimal sealing at both proximal and distal landing zones to avoid the risk of type I and III endoleaks
  • Conformability to complex aortic anatomy in challenging thoracoabdominal regions
  • Durability based on the with the multilayer braided design of the cobalt alloy wires
  • Low Profile, push-pull and kink-resistant reinforced delivery system

The Aortic MFM® is under clinical investigation for a total treatment of chronic type B aortic dissection. The MFM® restores the flow in the true lumen and ensures the thrombosis or the reduction of the false lumen while keeping branches patent.

Dr. Edward B. Diethrich talking about MFM®

Dimensions

Peripheral MFM®

Intended use

The Peripheral MFM® is currently CE-mark approved for endovascular treatment of patients with unruptured peripheral artery aneurysms (iliac, visceral, popliteal and subclavian arteries), with morphology suitable for endovascular repair.

Features

  • Physiological remodeling and healing of the aneurysmal artery while maintaining branch vessel patency
  • Endothelialization and integration, as the uncovered device allows endothelial tissue to be generated on the braided structure

  • Device lengths and conformability suitable for challenging popliteal regions

  • Durability based on the multilayer braided design of the cobalt alloy wires

 

Dimensions

Bifurcated MFM®

Intended use

The Bifurcated MFM®, using the CAMS BMFM delivery system, and including two bifurcation leg extension components (CAMS LE), is currently being investigated for endovascular treatment of patients with unruptured thoracoabdominal aortic aneurysms involving iliac arteries, with morphology suitable for endovascular repair.

Features

  • Physiological remodeling and healing of the aneurysmal artery while maintaining branch vessel patency
  • Endothelialization and integration as the uncovered device allows endothelial tissue to be generated on the braided structure
  • Pararenal and juxtarenal conformability, with renal artery coverage allowed due to the MFM® branch perfusion capabilities
  • Durability based on the multilayer braided design of the cobalt
    alloy wires320mm_std503160413_c_new2
  • Low-profile push-pull, and kink-resistant reinforced
    delivery system

 

 

 

Intracranial MFM®

Intended use

The Intracranial MFM® with the associated microcatheter system, is currently pending CE mark approval for endovascular treatment of patients with unruptured intracranial aneurysms with morphology suitable for endovascular repair.

Features

  • Physiological remodeling and healing of the aneurysmal artery while maintaining branch vessel patency
  • Endothelialization and integration as the uncovered device allows endothelial tissue to be generated on the braided structure
  • Unique structure and flexibility allowing optimal navigation